ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

Podrobná bibliografie
Hlavní autoři:	Snook, J, Chapman, R, Fleming, K, Jewell, D
Médium:	Journal article
Vydáno:	1988

Podobné jednotky

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Autor: Snook, J, a další
Vydáno: (1989)

The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
Autor: Mehal, W, a další
Vydáno: (1994)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
Autor: Snook, J, a další
Vydáno: (1987)

Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
Autor: Lo, S, a další
Vydáno: (1992)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
Autor: Lo, S, a další
Vydáno: (1991)

Primary sclerosing cholangitis--an immunologically mediated disease?
Autor: Chapman, R, a další
Vydáno: (1985)

Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
Autor: Saich, R, a další
Vydáno: (2008)

Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.
Autor: Snook, J, a další
Vydáno: (1989)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
Autor: Snook, J, a další
Vydáno: (1989)

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
Autor: You Sun Kim, a další
Vydáno: (2023-10-01)

The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
Autor: Chapman, R
Vydáno: (1995)

International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease
Autor: Williamson, K, a další
Vydáno: (2018)

SERUM ANTI-COLON ANTIBODIES, ULCERATIVE-COLITIS, AND SCLEROSING CHOLANGITIS
Autor: Chapman, R, a další
Vydáno: (1983)

Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases
Autor: Lynch, K, a další
Vydáno: (2019)

Chromoendoscopy in colorectal surveillance for primary sclerosing cholangitis and inflammatory bowel disease
Autor: Rodrigo V Motta, a další
Vydáno: (2025-01-01)

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
Autor: Satsangi, J, a další
Vydáno: (2000)

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
Autor: Boberg, K, a další
Vydáno: (2001)

Primary sclerosing cholangitis
Autor: Chapman, R
Vydáno: (2007)

Primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (1985)

Primary sclerosing cholangitis.
Autor: Cullen, S, a další
Vydáno: (2003)

Primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (2000)

Primary sclerosing cholangitis.
Autor: Williamson, K, a další
Vydáno: (2014)

Primary sclerosing cholangitis.
Autor: Worthington, J, a další
Vydáno: (2006)

Primary sclerosing cholangitis
Autor: Chapman Roger, a další
Vydáno: (2006-10-01)

Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
Autor: Ananthakrishnan, Ashwin N., a další
Vydáno: (2016)

Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
Autor: Joanna Saganek, a další
Vydáno: (2023-09-01)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
Autor: Kwang Woo Kim, a další
Vydáno: (2023-10-01)

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
Autor: Arshdeep Singh, a další
Vydáno: (2023-10-01)

Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis
Autor: Ingvar Bjarnason, a další
Vydáno: (2015-10-01)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
Autor: Cameron, B, a další
Vydáno: (1998)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
Autor: Bansi, D, a další
Vydáno: (1995)

A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment.
Autor: Lo, S, a další
Vydáno: (1994)

SERUM PROCOLLAGEN III N-TERMINAL PEPTIDE IN PRIMARY SCLEROSING CHOLANGITIS
Autor: Snook, J, a další
Vydáno: (1988)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
Autor: Martins, E, a další
Vydáno: (1995)

FEMALES WITH PRIMARY SCLEROSING CHOLANGITIS WITHOUT INFLAMMATORY BOWEL DISEASES HAVE A BETTER PROGNOSIS: IS IT DIFFERENT DISEASE?
Autor: Al Mamari, S, a další
Vydáno: (2013)

The management of primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (2003)

The immunology of primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (1990)

Primary sclerosing cholangitis - Foreword
Autor: Chapman, R
Vydáno: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
Autor: Chapman, R
Vydáno: (1993)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
Autor: Bansi, D, a další
Vydáno: (1995)